Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Abbott Laboratories (ABT) had Pre-Tax Income of $2.18B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.37B |
|
$1.64B |
|
$5.08B |
|
$6.29B |
|
$9.31B |
|
$2.06B |
|
$123.00M |
|
|
Pre-Tax Income |
$2.18B |
$2.18B |
|
$1.64B |
|
$1.64B |
|
$1.64B |
|
$1.64B |
|
$2.06B |
|
$2.85B |
|
1.74B |
|
1.75B |
|
$0.94 |
|
$0.94 |
|
| Balance Sheet Financials | |
$24.84B |
|
$11.50B |
|
$59.34B |
|
$84.18B |
|
$14.58B |
|
$11.60B |
|
$18.34B |
|
$32.92B |
|
$51.26B |
|
$21.70B |
|
$51.26B |
|
1.74B |
|
| Cash Flow Statement Financials | |
$6.25B |
|
$-1.51B |
|
$-4.91B |
|
$7.62B |
|
$7.51B |
|
$-105.00M |
|
$551.00M |
|
$-3.09B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
0.18 |
|
0.25 |
|
55.36% |
|
18.09% |
|
18.09% |
|
-- |
|
19.18% |
|
14.46% |
|
$4.77B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.76 |
|
1.40 |
|
64.42 |
|
3.21% |
|
7.58% |
|
1.95% |
|
2.62% |
|
$29.48 |
|
$2.73 |
|
$3.57 |
|